Singh A - Search Results

1

A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.

Najarian D, Sanga P, Wang S, Lim P, Singh A, Robertson MJ, Cohen K, Schotte A, Milz R, Venkatasubramanian R, T'Jollyn H, Walling DP, Galderisi S, Gopal S. Najarian D, et al. Among authors: singh a. Int J Neuropsychopharmacol. 2022 Mar 17;25(3):238-251. doi: 10.1093/ijnp/pyab071. Int J Neuropsychopharmacol. 2022. PMID: 34791283 Free PMC article. Clinical Trial.

2

The impracticality of surgically removing intramuscular long-acting injectable antipsychotic medication.

Kim E, Gopal S, O'Donnell A, Ramcharran D, Mathews M, Singh A. Kim E, et al. Among authors: singh a. Am J Emerg Med. 2018 Mar;36(3):522-523. doi: 10.1016/j.ajem.2017.08.012. Epub 2017 Aug 4. Am J Emerg Med. 2018. PMID: 28818307 No abstract available.

3

Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia.

Singh A, Gopal S, Kim E, Mathews M, Kern-Sliwa J, Turkoz I, Wooller A, Berlin J. Singh A, et al. Int Clin Psychopharmacol. 2018 Jul;33(4):213-216. doi: 10.1097/YIC.0000000000000215. Int Clin Psychopharmacol. 2018. PMID: 29494348 Free PMC article.

4

Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations.

Russu A, Kern Sliwa J, Ravenstijn P, Singh A, Mathews M, Kim E, Gopal S. Russu A, et al. Among authors: singh a. Int J Clin Pract. 2018 Jun;72(6):e13089. doi: 10.1111/ijcp.13089. Epub 2018 Apr 30. Int J Clin Pract. 2018. PMID: 29707876 Free PMC article.

5

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study.

Gopal S, Gogate J, Pungor K, Kim E, Singh A, Mathews M. Gopal S, et al. Among authors: singh a. Neuropsychiatr Dis Treat. 2020 Mar 6;16:681-690. doi: 10.2147/NDT.S226296. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32184607 Free PMC article.

6

Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies.

Mathews M, Gopal S, Singh A, Nuamah I, Pungor K, Tan W, Soares B, Kim E, Savitz AJ. Mathews M, et al. Among authors: singh a. Neuropsychiatr Dis Treat. 2020 Jun 19;16:1533-1542. doi: 10.2147/NDT.S221242. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32606705 Free PMC article.

7

Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.

Blackwood C, Sanga P, Nuamah I, Keenan A, Singh A, Mathews M, Gopal S. Blackwood C, et al. Among authors: singh a. Patient Prefer Adherence. 2020 Jul 2;14:1093-1102. doi: 10.2147/PPA.S251812. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 32753849 Free PMC article.

8

Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis.

Li G, Keenan A, Daskiran M, Mathews M, Nuamah I, Orman C, Joshi K, Singh A, Godet A, Pungor K, Gopal S. Li G, et al. Among authors: singh a. Patient Prefer Adherence. 2021 Oct 2;15:2239-2248. doi: 10.2147/PPA.S322880. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34629867 Free PMC article.

9

Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study.

Giron-Hernandez C, Han JH, Alberio R, Singh A, García-Portilla MP, Pompili M, Knight RK, Richarz U, Gopal S, Antunes J. Giron-Hernandez C, et al. Among authors: singh a. Neuropsychiatr Dis Treat. 2023 Apr 13;19:895-906. doi: 10.2147/NDT.S400342. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 37077705 Free PMC article.

10

Relationship between antipsychotic blood levels and treatment failure during the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

Melkote R, Singh A, Vermeulen A, Remmerie B, Savitz A. Melkote R, et al. Among authors: singh a. Schizophr Res. 2018 Nov;201:324-328. doi: 10.1016/j.schres.2018.05.028. Epub 2018 May 24. Schizophr Res. 2018. PMID: 29804929 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24,095 results

Search Page